or Try an Advanced Search...

    Technical Analysis for TYRA - Tyra Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 18.03 0.50% 0.09
    TYRA closed up 0.5 percent on Wednesday, May 8, 2024, on 49 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical TYRA trend table...
    Date Alert Name Type % Chg
    180 Bullish Setup Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Down Weakness 0.00%
    New Uptrend Bullish 0.50%
    Wide Bands Range Expansion 0.50%
    Overbought Stochastic Strength 0.50%
    Upper Bollinger Band Touch Strength 0.50%
    Stochastic Sell Signal Bearish -1.74%
    180 Bullish Setup Bullish Swing Setup -1.74%
    Inside Day Range Contraction -1.74%
    Older End-of-Day Signals for TYRA ...

       Recent Intraday Alerts

    Alert Time
    Up 1% about 14 hours ago
    Gap Down Closed about 14 hours ago
    Reversed from Down about 14 hours ago
    60 Minute Opening Range Breakout about 15 hours ago
    Gapped Down (Full) about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TYRA Chart by TradingView
    Basic chart:

    Profile

    Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Tumor Cell Biology Tyrosine Kinase Receptors Bladder Cancer Fibroblast Growth Factor Fibroblast Growth Factor Receptor Preclinical Stage Biopharmaceutical Clusters Of Differentiation

    Is TYRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
    Mar 20 Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress
    Mar 19 Tyra Biosciences GAAP EPS of -$0.53 misses by $0.05
    Mar 19 Tyra Biosciences files to sell 15.37M shares of common stock for holders
    Mar 19 Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
    Mar 6 Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares
    Mar 1 Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 8,644 Shares
    Feb 27 Tyra Biosciences to Present at Upcoming Investor Conferences
    Feb 7 Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences Conference
    Feb 7 President and CEO Todd Harris Sells 100,000 Shares of Tyra Biosciences Inc (TYRA)
    See more TYRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.67
    52 Week Low 10.47
    Average Volume 140,925
    200-Day Moving Average 14.90
    50-Day Moving Average 17.21
    20-Day Moving Average 16.23
    10-Day Moving Average 17.33
    Average True Range 1.06
    RSI (14) 59.02
    ADX 25.65
    +DI 32.10
    -DI 15.92
    Chandelier Exit (Long, 3 ATRs) 16.12
    Chandelier Exit (Short, 3 ATRs) 17.29
    Upper Bollinger Bands 19.09
    Lower Bollinger Band 13.38
    Percent B (%b) 0.81
    BandWidth 35.18
    MACD Line 0.42
    MACD Signal Line 0.10
    MACD Histogram 0.3216
    Fundamentals Value
    Market Cap 943.78 Million
    Num Shares 52.3 Million
    EPS -1.39
    Price-to-Earnings (P/E) Ratio -12.97
    Price-to-Sales 0.00
    Price-to-Book 4.30
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 19.54
    Resistance 3 (R3) 19.45 18.85 19.29
    Resistance 2 (R2) 18.85 18.47 18.90 19.20
    Resistance 1 (R1) 18.44 18.23 18.65 18.53 19.12
    Pivot Point 17.85 17.85 17.95 17.89 17.85
    Support 1 (S1) 17.44 17.46 17.64 17.53 16.94
    Support 2 (S2) 16.84 17.22 16.89 16.86
    Support 3 (S3) 16.43 16.84 16.77
    Support 4 (S4) 16.52